Stock Price Updates, Earnings Releases, and Recognitions - Analyst Notes on Monster Beverage, Colgate-Palmolive, Progressive, Franklin and Zimmer

NEW YORK, May 14, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Monster Beverage Corporation (NASDAQ: MNST), Colgate-Palmolive Co. (NYSE: CL), Progressive Corp. (NYSE: PGR), Franklin Resources Inc. (NYSE: BEN) and Zimmer Holdings, Inc. (NYSE: ZMH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2432-100free.

--
Monster Beverage Corporation Analyst Notes
On May 8, 2014, Monster Beverage Corporation (Monster Beverage) released its financial results for Q1 2014. Monster Beverage's net sales during the quarter went up by 10.7% YoY to $536.1 million, but fell short of Wall Street analysts' consensus estimate of $542.3 million. The Company noted that results continue to be negatively impacted by professional service costs related to regulatory matters and litigation concerning the marketing, ingredients, usage, safety and sale of its Monster Energy brand energy drinks. While top-line fell short of the expectations, the Company's profit surpassed analysts' estimates. Monster Beverage's net income in the quarter increased to $95.3 million, or $0.55 per diluted share, from $63.5 million, or $0.37 per diluted share, in year-ago period. On average, 11 analysts polled by Thomson Reuters expected the Company to report earnings per share of $0.49 (excluding special items) for Q1 2014. The full analyst notes on Monster Beverage are available to download free of charge at:

http://www.analystsreview.com/2432-MNST-14May2014.pdf

--
Colgate-Palmolive Co. Analyst Notes
On April 25, 2014, Colgate-Palmolive Co. (Colgate-Palmolive) reported its Q1 2014 financial results. The global consumer products Company registered a non-GAAP net income of $0.68 per diluted share, an increase of 3.0% YoY, and in line with the Reuters analysts' average estimates. The GAAP net income of the Company was down at $388 million, or $0.42 per diluted share, from $460 million, or $0.48 per diluted share, in Q1 2013. Colgate noted that the GAAP net income includes an aftertax charge of $174 million ($0.19 per diluted share) related to fall in the value of Venezuelan currency. Colgate's net sales during the quarter increased marginally to $4.33 billion from $4.32 billion in Q1 2013. Colgate Chairman, President and CEO, Ian Cook said the Company expects diluted EPS for full-year 2014 to grow 4% to 5% on a dollar basis and at a double-digit rate on a currency neutral basis. The full analyst notes on Colgate-Palmolive are available to download free of charge at:

http://www.analystsreview.com/2432-CL-14May2014.pdf

--
Progressive Corp. Analyst Notes
On May 9, 2014, shares of Progressive Corp. (Progressive) - the insurance holding Company -- ended flat with a positive bias at $24.64. Overall, the U.S. markets saw a positive sentiment with Dow Jones Industrial Average (DJIA) reaching a record new high of 16,583.34, up 0.20% from its previous day's close. Meanwhile, the shares of Progressive opened at $24.60 and traded in the range of $24.65-$24.50. A total of 6.6 million shares changed hands, higher than the 30-day average trading volume of 4.75 million shares. Over the past three-months, the stock of Progressive gained an upside of 4.90%, compared with the DJIA, which returned 3.38% over the same time period. The full analyst notes on Progressive are available to download free of charge at:

http://www.analystsreview.com/2432-PGR-14May2014.pdf

--
Franklin Resources Inc. Analyst Notes
On May 8, 2014, Franklin Resources Inc. (Franklin) reported preliminary month-end assets under management (AUM) by the Company's subsidiaries of $895.4 billion at April 30, 2014, compared to $886.9 billion at March 31, 2014, and $847.5 billion at April 30, 2013. As of April 30, 2014, Fixed Income AUM and Equity AUM represented 45.3% and 38.5% of the Franklin Templeton Investments' total AUM, respectively. On April 28, 2014, the Company announced its Q2 FY 2014 financial results. The investment management firm reported a net income of $561.0 million, or $0.89 per diluted share, as compared $572.8 million, or $0.90 per diluted share, in Q2 FY 2013. The full analyst notes on Franklin are available to download free of charge at:

http://www.analystsreview.com/2432-BEN-14May2014.pdf

--
Zimmer Holdings, Inc. Analyst Notes
On May 7, 2014, Zimmer Holdings, Inc. (Zimmer) announced that the Company's personalized knee system - Persona, has been named a category finalist for the 2014 Medical Design Excellence Awards (MDEA). Stephen E. White, Senior Vice President and General Manager, Knees, for Zimmer said, "The Persona Knee offers an unparalleled combination of experience and range of innovative features and technologies, in a product system that achieves superior levels of personalization." The awards for the 2014 MDEA program will be announced on June 11, 2014 in New York City as part of MD&M East, which will be held during June 9-12, 2014. Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. The full analyst notes on Zimmer are available to download free of charge at:

http://www.analystsreview.com/2432-ZMH-14May2014.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED